Yi Gong

ORCID: 0000-0002-6619-8748
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV, Drug Use, Sexual Risk
  • Substance Abuse Treatment and Outcomes
  • Opioid Use Disorder Treatment
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • HIV, TB, and STIs Epidemiology
  • Blood Pressure and Hypertension Studies
  • Energy and Environment Impacts
  • Air Quality and Health Impacts
  • Asthma and respiratory diseases
  • Pediatric health and respiratory diseases
  • HIV/AIDS Research and Interventions
  • Liver Disease and Transplantation

Second Xiangya Hospital of Central South University
2022-2025

Central South University
2022-2025

Sichuan Center for Disease Control and Prevention
2015-2024

Background Liver cirrhosis-related death is a serious threat worldwide. The number of studies exploring the mortality trend cirrhosis caused by specific etiologies was limited. This study aimed to demonstrate pattern and based on data global burden disease (GBD). Methods were collected from GBD 2017. Age standardized rate (ASR) estimated annual percentage changes (EAPC) used estimate temporal liver etiologies, regions, sociodemographic index (SDI), sexes. Results Globally, cases increased...

10.3389/fpubh.2022.909455 article EN cc-by Frontiers in Public Health 2022-08-11

This study aims to analyze and identify primary research trends in targeted therapy for thyroid carcinoma (TC). It seeks provide a factual foundation researchers, as TC often presents with advanced stages aggressive subtypes, leading unfavorable clinical outcomes. The evolution of therapies introduces promising treatment possibilities, necessitating bibliometric analysis better understand the current state this field. A comprehensive was conducted using data from Web Science Core Collection...

10.1097/md.0000000000041835 article EN cc-by-nc Medicine 2025-03-14

Although methadone for addiction treatment (MAT) has been widely used in China, the low adherence rate MAT clinics poses a great challenge. We aimed to investigate factors related of heroin-dependent patients based on Health Belief Model (HBM) Sichuan, China.A cross-sectional structured interview was conducted between August and November 2018. Stratified multi-stage sampling carried out. A total 581 participants were enrolled from 5 completed face-to-face interview. Univariate, adjusted...

10.1097/adm.0000000000000640 article EN Journal of Addiction Medicine 2020-03-05

SUMMARY Hepatitis C virus (HCV) has become a global public health problem. Many studies have been conducted to identify risk factors for HCV infection. However, some of these reported inconsistent results. Using data collected from 11 methadone clinics, we fit both non-spatial logistical regression and geographically weighted logistic analyse the association between infection at individual level. This study enrolled 5401 patients with 30·0% prevalence. The found that injection history, drug...

10.1017/s0950268815002666 article EN Epidemiology and Infection 2015-11-06

Abstract Covertly using heroin during methadone maintenance treatment (MMT) is very common among heroin-dependent patients, which has posed threats to the physical health of patients and social safety. may be influenced by many factors, especially capital. Therefore, we aimed investigate relationship between behaviors covertly MMT capital in Sichuan Province, China. A cross-sectional study was conducted October November 2018, with a total 581 participating study. In addition...

10.1097/md.0000000000019963 article EN cc-by-nc Medicine 2020-06-11

Objective: To analyze the survival time of people living with HIV/AIDS and related influencing factors in Sichuan province during 1991-2017. Methods: A retrospective cohort study was conducted to data 143 988 cases. The were collected from Chinese Comprehensive Information Management System. Life table method used calculate proportion cases, Cox hazard regression model identify time. Results: Among cases a total 30 420 died AIDS diseases (21.1%) average 11.51 years (95%CI: 11.39-11.64)....

10.3760/cma.j.issn.0254-6450.2019.03.010 article EN PubMed 2019-03-10
Coming Soon ...